These man-made cancer-fighting molecules are infinitely variable, like a set of Legos, each one constructed to allow a patient’s immune cells to...
Day: 22 August 2018
First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded...
Selinexor and Multiple Myeloma
There are various treatment options for patients with multiple myeloma (MM), including autologous hematopoietic stem cell transplantation (HSCT),...
Georgia woman hopes experimental “living” cancer therapy will stop her myeloma
For 48-year old Atlanta mom, wife and dog groomer Cheri Letts, the realization she was sick came slowly. "I was starting to feel rundown, and it...
Advances Could Lead to Curative Strategies in Myeloma
There are currently 10 FDA-approved treatments in the multiple myeloma space; however, a more personalized therapy could be key to finding a cure,...
Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis
Background:Â The refractory/relapsed multiple myeloma (RRMM) remains a big clinical challenge, due to its biological and clinical complexity. Leading...
Two molecules offer great potential to combat cancer and chronic infections
To fight viral infections, your immune system calls on CD8 T cells to kill the infected cells. The CD8 T cells can also be used in immunotherapy...